Clinical trial
Cranoc Lipid Study in Renal Transplantation
NCT00223041 · University Hospital Schleswig-Holstein, Other · Terminated
Key facts
| NCT number | NCT00223041 |
|---|---|
| Title | Cranoc Lipid Study in Renal Transplantation |
| Official title | Cardiovascular Events in Renal Transplant Recipients With Low LDL-cholesterol Receiving Tacrolimus in Combination With the Statin Fluvastatin |
| Lead sponsor | University Hospital Schleswig-Holstein, Other |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | Fluvastatin |
| Enrollment | 200 |
| Start date | Apr 1, 2003 |
| Primary completion | Nov 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 8, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: